|
GS165707: MP:0000428 abnormal craniofacial morphology
|
|
GS185131: GO:0044699 single-organism process
|
|
GS187248: GO:0072359 circulatory system development
|
|
GS202082: GO:0051254 positive regulation of RNA metabolic process
|
|
GS166501: MP:0003189 fused joints
|
|
GS180039: GO:0032504 multicellular organism reproduction
|
|
GS165814: MP:0001922 reduced male fertility
|
|
GS185261: GO:0051254 positive regulation of RNA metabolic process
|
|
GS198861: GO:0007167 enzyme linked receptor protein signaling pathway
|
|
GS163534: MP:0004653 absent caudal vertebrae
|
|
GS203018: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
|
|
GS164506: MP:0001698 decreased embryo size
|
|
GS167779: MP:0002632 vestigial tail
|
|
GS179428: GO:0022414 reproductive process
|
|
GS135641: circadian photosensitivity 2 (Circp2, Published QTL Chr 17)
|
|
GS191083: GO:0000003 reproduction
|
|
GS167063: MP:0001929 abnormal gametogenesis
|
|
GS191669: GO:0001067 regulatory region nucleic acid binding
|
|
GS167156: MP:0000459 abnormal presacral vertebrae morphology
|
|
GS195583: GO:0019953 sexual reproduction
|
|
GS180671: GO:0044454 nuclear chromosome part
|
|
GS199273: GO:0043233 organelle lumen
|
|
GS166753: MP:0001935 decreased litter size
|
|
GS191019: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS163537: MP:0004656 absent sacral vertebrae
|
|
GS187887: GO:0080090 regulation of primary metabolic process
|
|
GS165643: MP:0011088 partial neonatal lethality
|
|
GS136170: leishmaniasis resistance 7 (Lmr7, Published QTL Chr 17)
|
|
GS177505: GO:0035148 tube formation
|
|
GS190039: GO:0009566 fertilization
|
|
GS195460: GO:0060348 bone development
|
|
GS203054: GO:0048514 blood vessel morphogenesis
|
|
GS163579: MP:0000539 distended urinary bladder
|
|
GS189669: GO:2000112 regulation of cellular macromolecule biosynthetic process
|
|
GS206108: GO:2001141 regulation of RNA biosynthetic process
|
|
GS192017: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS166225: MP:0009850 embryonic lethality between implantation and placentation
|
|
GS194417: GO:0000790 nuclear chromatin
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS167042: MP:0003885 abnormal rostral-caudal body axis extension
|
|
GS177265: GO:0048731 system development
|
|
GS207925: GO:0034645 cellular macromolecule biosynthetic process
|
|
GS201251: GO:0044424 intracellular part
|
|
GS193238: GO:0031323 regulation of cellular metabolic process
|
|
GS201404: GO:0009952 anterior/posterior pattern specification
|
|
GS203908: GO:0016070 RNA metabolic process
|
|
GS181893: GO:0048522 positive regulation of cellular process
|
|
GS163552: MP:0001684 abnormal axial mesoderm
|
|
GS188142: GO:0048856 anatomical structure development
|
|
GS165194: MP:0001533 abnormal skeleton physiology
|
|
GS165228: MP:0005382 craniofacial phenotype
|
|
GS164333: MP:0000516 abnormal renal/urinary system morphology
|
|
GS187973: GO:0061053 somite development
|
|
GS192829: GO:0021915 neural tube development
|
|
GS170243: MP:0011085 complete postnatal lethality
|
|
GS163650: MP:0004179 transmission ratio distortion
|
|
GS209551: GO:0031981 nuclear lumen
|
|
GS164258: MP:0002084 abnormal developmental patterning
|
|
GS193414: GO:0044249 cellular biosynthetic process
|
|
GS169928: MP:0004173 abnormal intervertebral disk morphology
|
|
GS186892: GO:0001840 neural plate development
|
|
GS169735: MP:0004543 abnormal sperm physiology
|
|
GS163067: MP:0005034 abnormal anus morphology
|
|
GS199757: GO:0035239 tube morphogenesis
|
|
GS199937: GO:0030509 BMP signaling pathway
|
|
GS198051: GO:0048562 embryonic organ morphogenesis
|
|
GS178922: GO:0003700 sequence-specific DNA binding transcription factor activity
|
|
GS201125: GO:0009790 embryo development
|
|
GS190393: GO:0007338 single fertilization
|
|
GS135556: CD8 memory T cell subset 5 (Cd8mts5, Published QTL Chr 17)
|
|
GS164406: MP:0004609 vertebral fusion
|
|
GS188757: GO:0009887 organ morphogenesis
|
|
GS190817: GO:0048609 multicellular organismal reproductive process
|
|
GS193937: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS163627: MP:0001930 abnormal meiosis
|
|
GS179767: GO:0000976 transcription regulatory region sequence-specific DNA binding
|
|
GS199620: GO:0060429 epithelium development
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS169460: MP:0004713 split notochord
|
|
GS179769: GO:0000975 regulatory region DNA binding
|
|
GS204628: GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway
|
|
GS166409: MP:0002114 abnormal axial skeleton morphology
|
|
GS189484: GO:0023052 signaling
|
|
GS208231: GO:1901213 regulation of transcription from RNA polymerase II promoter involved in heart development
|
|
GS195143: GO:0016055 Wnt receptor signaling pathway
|
|
GS136120: body length 9 (Lgth9, Published QTL Chr 17)
|
|
GS195643: GO:0003677 DNA binding
|
|
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS204472: GO:1901228 positive regulation of transcription from RNA polymerase II promoter involved in heart development
|
|
GS207720: GO:0048609 multicellular organismal reproductive process
|
|
GS135861: femur breaking strength 4 (Fembrs4, Published QTL Chr 17)
|
|
GS184317: GO:0009790 embryo development
|
|
GS164082: MP:0004672 short ribs
|
|
GS209956: GO:0003002 regionalization
|
|
GS195340: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS196532: GO:0000975 regulatory region DNA binding
|
|
GS168408: MP:0000585 kinked tail
|
|
GS186744: GO:0043226 organelle
|
|
GS163462: MP:0005650 abnormal limb bud morphology
|
|
GS167070: MP:0001921 reduced fertility
|
|
GS169828: MP:0005386 behavior/neurological phenotype
|
|
GS181035: GO:0001704 formation of primary germ layer
|
|
GS182835: GO:0005622 intracellular
|
|
GS166438: MP:0002231 abnormal primitive streak morphology
|
|
GS204511: GO:0048729 tissue morphogenesis
|
|
GS201756: GO:0042692 muscle cell differentiation
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS206544: GO:2000112 regulation of cellular macromolecule biosynthetic process
|
|
GS135331: autoimmune susceptibility in C57BL/6J and BALB/c 3 (Asbb3, Published QTL Chr 17)
|
|
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS210178: GO:0031328 positive regulation of cellular biosynthetic process
|
|
GS169832: MP:0005381 digestive/alimentary phenotype
|
|
GS206923: GO:0009566 fertilization
|
|
GS181972: GO:0001838 embryonic epithelial tube formation
|
|
GS204108: GO:0072358 cardiovascular system development
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS198360: GO:0006357 regulation of transcription from RNA polymerase II promoter
|
|
GS203406: GO:0009653 anatomical structure morphogenesis
|
|
GS206282: GO:0003257 positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation
|
|
GS84301: ethanol conditioned taste aversion (Published QTL, Chr 17)
|
|
GS164068: MP:0008854 bleb
|
|
GS166533: MP:0004509 abnormal pelvic girdle bone morphology
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS163042: MP:0000269 abnormal heart looping
|
|
GS165805: MP:0002861 abnormal tail bud morphology
|
|
GS189415: GO:0003256 regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation
|
|
GS121161: Arsenic interacting genes (MeSH:D001151) in CTD
|
|
GS164372: MP:0004668 absent vertebral body
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS199501: GO:0051173 positive regulation of nitrogen compound metabolic process
|
|
GS136265: modifier of mammary tumor progression 2 (Mmtp2, Published QTL Chr 17)
|
|
GS166437: MP:0002230 abnormal primitive streak formation
|
|
GS184318: GO:0009792 embryo development ending in birth or egg hatching
|
|
GS206329: GO:0060255 regulation of macromolecule metabolic process
|
|
GS207210: GO:0035295 tube development
|
|
GS135250: adiposity 18 (Adip18, Published QTL Chr 17)
|
|
GS185545: GO:0044212 transcription regulatory region DNA binding
|
|
GS195199: GO:0005634 nucleus
|
|
GS193234: GO:0031328 positive regulation of cellular biosynthetic process
|
|
GS166118: MP:0002109 abnormal limb morphology
|
|
GS201126: GO:0009792 embryo development ending in birth or egg hatching
|
|
GS136482: plasmacytoma susceptibility 4 (Pcyts4, Published QTL Chr 17)
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS136634: small effect CIA locus 8 (Secia8, Published QTL Chr 17)
|
|
GS166581: MP:0004599 abnormal vertebral arch morphology
|
|
GS189240: GO:2001141 regulation of RNA biosynthetic process
|
|
GS206281: GO:0003256 regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation
|
|
GS165361: MP:0004624 abnormal thoracic cage morphology
|
|
GS166615: MP:0003410 abnormal artery development
|
|
GS186893: GO:0001843 neural tube closure
|
|
GS193857: GO:0055007 cardiac muscle cell differentiation
|
|
GS164488: MP:0005225 abnormal vertebrae development
|
|
GS182820: GO:0060429 epithelium development
|
|
GS186178: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS166590: MP:0002873 normal phenotype
|
|
GS163052: MP:0000266 abnormal heart morphology
|
|
GS182325: GO:0051716 cellular response to stimulus
|
|
GS198765: GO:0001838 embryonic epithelial tube formation
|
|
GS202371: GO:0044212 transcription regulatory region DNA binding
|
|
GS194159: GO:0009799 specification of symmetry
|
|
GS187343: GO:0006351 transcription, DNA-dependent
|
|
GS127012: Raloxifene interacting genes (MeSH:D020849) in CTD
|
|
GS209951: GO:0042127 regulation of cell proliferation
|
|
GS168920: MP:0002674 abnormal sperm motility
|
|
GS169391: MP:0002066 abnormal motor capabilities/coordination/movement
|
|
GS184731: GO:0035326 enhancer binding
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS169178: MP:0004073 caudal body truncation
|
|
GS163813: MP:0004645 decreased vertebrae number
|
|
GS181473: GO:0005488 binding
|
|
GS184445: GO:0044428 nuclear part
|
|
GS136304: modifier of Yaa 1 (Myaa1, Published QTL Chr 17)
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS192345: GO:0010628 positive regulation of gene expression
|
|
GS196930: GO:0065007 biological regulation
|
|
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS177859: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS191150: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS181034: GO:0001707 mesoderm formation
|
|
GS163484: MP:0004837 abnormal neural fold formation
|
|
GS165365: MP:0004620 cervical vertebral fusion
|
|
GS198004: GO:0007399 nervous system development
|
|
GS168687: MP:0000592 short tail
|
|
GS169389: MP:0002060 abnormal skin morphology
|
|
GS164264: MP:0002082 postnatal lethality
|
|
GS204746: GO:0080090 regulation of primary metabolic process
|
|
GS197825: GO:0001704 formation of primary germ layer
|
|
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
|
|
GS201249: GO:0044428 nuclear part
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS169889: MP:0009053 abnormal anal canal morphology
|
|
GS185438: GO:0001568 blood vessel development
|
|
GS193991: GO:0048731 system development
|
|
GS198456: GO:0019438 aromatic compound biosynthetic process
|
|
GS163546: MP:0001688 abnormal somite development
|
|
GS166157: MP:0011097 complete embryonic lethality between somite formation and embryo turning
|
|
GS170137: MP:0001712 abnormal placenta development
|
|
GS183891: GO:0002009 morphogenesis of an epithelium
|
|
GS209775: GO:0021915 neural tube development
|
|
GS167074: MP:0001925 male infertility
|
|
GS166272: MP:0000288 abnormal pericardium morphology
|
|
GS181667: GO:0019438 aromatic compound biosynthetic process
|
|
GS165489: MP:0001700 abnormal embryo turning
|
|
GS204107: GO:0072359 circulatory system development
|
|
GS165163: MP:0006205 embryonic lethality between implantation and somite formation
|
|
GS190900: GO:0043009 chordate embryonic development
|
|
GS164514: MP:0001690 failure of somite differentiation
|
|
GS194088: GO:0003676 nucleic acid binding
|
|
GS178243: GO:0001158 enhancer sequence-specific DNA binding
|
|
GS188511: GO:0010468 regulation of gene expression
|
|
GS193014: GO:0003002 regionalization
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS163899: MP:0000495 abnormal colon morphology
|
|
GS180089: GO:0030903 notochord development
|
|
GS209199: GO:0007165 signal transduction
|
|
GS178589: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS184447: GO:0044424 intracellular part
|
|
GS187162: GO:0014028 notochord formation
|
|
GS193236: GO:0031326 regulation of cellular biosynthetic process
|
|
GS194519: GO:0014706 striated muscle tissue development
|
|
GS207813: GO:0048332 mesoderm morphogenesis
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS202417: GO:0007368 determination of left/right symmetry
|
|
GS193072: GO:0060562 epithelial tube morphogenesis
|
|
GS170051: MP:0011495 abnormal head shape
|
|
GS168369: MP:0011256 abnormal neural fold morphology
|
|
GS167503: MP:0003054 spina bifida
|
|
GS191021: GO:0034645 cellular macromolecule biosynthetic process
|
|
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS188272: GO:0035051 cardiac cell differentiation
|
|
GS203335: GO:0048513 organ development
|
|
GS180916: GO:0016331 morphogenesis of embryonic epithelium
|
|
GS188684: GO:0070013 intracellular organelle lumen
|
|
GS197049: GO:0009948 anterior/posterior axis specification
|
|
GS207298: GO:0072175 epithelial tube formation
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS166712: MP:0002161 abnormal fertility/fecundity
|
|
GS200690: GO:0002009 morphogenesis of an epithelium
|
|
GS201848: GO:0048598 embryonic morphogenesis
|
|
GS135877: femur geometry 14 (Fmgty14, Published QTL Chr 17)
|
|
GS129164: progressive hearing loss 1 (Phl1 Published QTL Chr 17)
|
|
GS196540: GO:0043565 sequence-specific DNA binding
|
|
GS169477: MP:0006392 abnormal nucleus pulposus morphology
|
|
GS189794: GO:0000980 RNA polymerase II distal enhancer sequence-specific DNA binding
|
|
GS169017: MP:0002932 abnormal joint morphology
|
|
GS182475: GO:0043233 organelle lumen
|
|
GS193987: GO:0048738 cardiac muscle tissue development
|
|
GS196531: GO:0000977 RNA polymerase II regulatory region sequence-specific DNA binding
|
|
GS188506: GO:0010467 gene expression
|
|
GS208012: GO:0044464 cell part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS195291: GO:0006355 regulation of transcription, DNA-dependent
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS205369: GO:0010468 regulation of gene expression
|
|
GS188763: GO:0009888 tissue development
|
|
GS192073: GO:1901576 organic substance biosynthetic process
|
|
GS36670: Hippocampus Gene expression correlates of Morphine vertical activity counts minutes 165-180 in Males BXD
|
|
GS181262: GO:0048562 embryonic organ morphogenesis
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS188762: GO:0009889 regulation of biosynthetic process
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS208060: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS193663: GO:0048570 notochord morphogenesis
|
|
GS169115: MP:0009929 meningomyelocele
|
|
GS184435: GO:0046483 heterocycle metabolic process
|
|
GS186395: GO:0000228 nuclear chromosome
|
|
GS187370: GO:0001071 nucleic acid binding transcription factor activity
|
|
GS203402: GO:0007498 mesoderm development
|
|
GS164261: MP:0002081 perinatal lethality
|
|
GS178827: GO:0019953 sexual reproduction
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS187545: GO:0060606 tube closure
|
|
GS201858: GO:0009855 determination of bilateral symmetry
|
|
GS194038: GO:1901362 organic cyclic compound biosynthetic process
|
|
GS165612: MP:0002128 abnormal blood circulation
|
|
GS204019: GO:0014020 primary neural tube formation
|
|
GS205623: GO:0009888 tissue development
|
|
GS204440: GO:0010002 cardioblast differentiation
|
|
GS168295: MP:0003698 abnormal male reproductive system physiology
|
|
GS166822: MP:0000461 decreased presacral vertebrae number
|
|
GS166194: MP:0009931 abnormal skin appearance
|
|
GS168088: MP:0011110 partial preweaning lethality
|
|
GS167525: MP:0000154 rib fusion
|
|
GS163050: MP:0000260 abnormal angiogenesis
|
|
GS129089: bronchial hyperresponsiveness 3 (Bhr3 Published QTL Chr 17)
|
|
GS194206: GO:0007341 penetration of zona pellucida
|
|
GS193012: GO:0003007 heart morphogenesis
|
|
GS207807: GO:0043009 chordate embryonic development
|
|
GS166711: MP:0002160 abnormal reproductive system morphology
|
|
GS177310: GO:1901360 organic cyclic compound metabolic process
|
|
GS168149: MP:0005508 abnormal skeleton morphology
|
|
GS164588: MP:0003051 curly tail
|
|
GS167020: MP:0003956 abnormal body size
|
|
GS165616: MP:0002127 abnormal cardiovascular system morphology
|
|
GS179357: GO:0001012 RNA polymerase II regulatory region DNA binding
|
|
GS210180: GO:0031326 regulation of cellular biosynthetic process
|
|
GS169833: MP:0005380 embryogenesis phenotype
|
|
GS182834: GO:0005623 cell
|
|
GS194991: GO:0001158 enhancer sequence-specific DNA binding
|
|
GS205622: GO:0009889 regulation of biosynthetic process
|
|
GS208657: GO:0008284 positive regulation of cell proliferation
|
|
GS191151: GO:0010556 regulation of macromolecule biosynthetic process
|
|
GS198056: GO:0048568 embryonic organ development
|
|
GS209282: GO:0010628 positive regulation of gene expression
|
|
GS121593: 2-amino-4-phosphonobutyric acid interacting genes (MeSH:C012729) in CTD
|
|
GS189460: GO:0060255 regulation of macromolecule metabolic process
|
|
GS183137: GO:0030509 BMP signaling pathway
|
|
GS169530: MP:0005390 skeleton phenotype
|
|
GS178448: GO:0005634 nucleus
|
|
GS84298: cocaine induced activation (Published QTL, Chr 17)
|
|
GS187768: GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS165075: MP:0005227 abnormal vertebral body development
|
|
GS184118: GO:0023019 signal transduction involved in regulation of gene expression
|
|
GS168012: MP:0010832 lethality during fetal growth through weaning
|
|
GS179768: GO:0000977 RNA polymerase II regulatory region sequence-specific DNA binding
|
|
GS168013: MP:0010831 partial lethality
|
|
GS185043: GO:0009855 determination of bilateral symmetry
|
|
GS197824: GO:0001707 mesoderm formation
|
|
GS167075: MP:0001924 infertility
|
|
GS208061: GO:0010556 regulation of macromolecule biosynthetic process
|
|
GS178537: GO:0006355 regulation of transcription, DNA-dependent
|
|
GS185937: GO:0005694 chromosome
|
|
GS189820: GO:0044702 single organism reproductive process
|
|
GS196943: GO:0008152 metabolic process
|
|
GS187146: GO:0044700 single organism signaling
|
|
GS204023: GO:0014028 notochord formation
|
|
GS202261: GO:0001568 blood vessel development
|
|
GS168379: MP:0002151 abnormal neural tube morphology/development
|
|
GS185740: GO:0048706 embryonic skeletal system development
|
|
GS199612: GO:0061371 determination of heart left/right asymmetry
|
|
GS167224: MP:0000141 abnormal vertebral body morphology
|
|
GS165244: MP:0010771 integument phenotype
|
|
GS196941: GO:0008150 biological_process
|
|
GS187610: GO:1901228 positive regulation of transcription from RNA polymerase II promoter involved in heart development
|
|
GS182069: GO:0007167 enzyme linked receptor protein signaling pathway
|
|
GS199634: GO:0005623 cell
|
|
GS165567: MP:0008271 abnormal bone ossification
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS169461: MP:0004712 notochord degeneration
|
|
GS162909: MP:0008999 absent anus
|
|
GS164105: MP:0003047 abnormal thoracic vertebrae morphology
|
|
GS190893: GO:0030154 cell differentiation
|
|
GS197470: GO:0044454 nuclear chromosome part
|
|
GS187648: GO:0048729 tissue morphogenesis
|
|
GS186079: GO:0035282 segmentation
|
|
GS187045: GO:0016070 RNA metabolic process
|
|
GS201256: GO:0044422 organelle part
|
|
GS168151: MP:0001914 hemorrhage
|
|
GS205616: GO:0009887 organ morphogenesis
|
|
GS162897: MP:0003984 embryonic growth retardation
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS209954: GO:0003007 heart morphogenesis
|
|
GS210182: GO:0031323 regulation of cellular metabolic process
|
|
GS187158: GO:0014020 primary neural tube formation
|
|
GS189416: GO:0003257 positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation
|
|
GS195060: GO:0051146 striated muscle cell differentiation
|
|
GS200744: GO:0000578 embryonic axis specification
|
|
GS207964: GO:0007509 mesoderm migration involved in gastrulation
|
|
GS165214: MP:0001711 abnormal placenta morphology
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS186211: GO:0048514 blood vessel morphogenesis
|
|
GS187578: GO:0010002 cardioblast differentiation
|
|
GS124911: PD 169316 interacting genes (MeSH:C408604) in CTD
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS177761: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS168921: MP:0002675 asthenozoospermia
|
|
GS190682: GO:0007275 multicellular organismal development
|
|
GS169185: MP:0000755 hindlimb paralysis
|
|
GS166925: MP:0002825 abnormal notochord morphology
|
|
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS169172: MP:0006386 absent somites
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS167796: MP:0008770 decreased survivor rate
|
|
GS210181: GO:0031325 positive regulation of cellular metabolic process
|
|
GS167047: MP:0004573 absent limb buds
|
|
GS87065: Table S4: List of Saline-Treated HDAC5 KO vs. Saline-Treated WT Significantly Regulated Genes. [DRG]
provisional
|
|
GS182074: GO:0000785 chromatin
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS166427: MP:0004608 abnormal cervical axis morphology
|
|
GS191312: GO:1901213 regulation of transcription from RNA polymerase II promoter involved in heart development
|
|
GS135576: cystic fibrosis lung disease 3 (Cfld3, Published QTL Chr 17)
|
|
GS136800: total body bone mineral density 7 (Tbbmd7, Published QTL Chr 17)
|
|
GS202080: GO:0051252 regulation of RNA metabolic process
|
|
GS166579: MP:0005221 abnormal rostral-caudal axis patterning
|
|
GS170198: MP:0001614 abnormal blood vessel morphology
|
|
GS165160: MP:0006207 embryonic lethality during organogenesis
|
|
GS170107: MP:0003720 abnormal neural tube closure
|
|
GS204568: GO:0009893 positive regulation of metabolic process
|
|
GS163620: MP:0002086 abnormal extraembryonic tissue morphology
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS165427: MP:0000432 abnormal head morphology
|
|
GS192357: GO:0036342 post-anal tail morphogenesis
|
|
GS191057: GO:0007509 mesoderm migration involved in gastrulation
|
|
GS164968: MP:0001726 abnormal allantois morphology
|
|
GS136400: organ weight 9 (Org9, Published QTL Chr 17)
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS180437: GO:0001570 vasculogenesis
|
|
GS184629: GO:0005515 protein binding
|
|
GS169603: MP:0001672 abnormal embryogenesis/ development
|
|
GS164482: MP:0001216 abnormal epidermal layer morphology
|
|
GS166404: MP:0002113 abnormal skeleton development
|
|
GS185735: GO:0048705 skeletal system morphogenesis
|
|
GS196811: GO:0032504 multicellular organism reproduction
|
|
GS202775: GO:0005694 chromosome
|
|
GS179211: GO:0007154 cell communication
|
|
GS205127: GO:0035051 cardiac cell differentiation
|
|
GS192265: GO:0007165 signal transduction
|
|
GS196124: GO:0001012 RNA polymerase II regulatory region DNA binding
|
|
GS180152: GO:0065007 biological regulation
|
|
GS177472: GO:0007341 penetration of zona pellucida
|
|
GS184601: GO:0009952 anterior/posterior pattern specification
|
|
GS166793: MP:0006279 abnormal limb development
|
|
GS165536: MP:0005371 limbs/digits/tail phenotype
|
|
GS186488: GO:0048513 organ development
|
|
GS165397: MP:0001265 decreased body size
|
|
GS178393: GO:0016055 Wnt receptor signaling pathway
|
|
GS191030: GO:0007507 heart development
|
|
GS164450: MP:0005191 head tilt
|
|
GS169095: MP:0004924 abnormal behavior
|
|
GS164624: MP:0004613 fusion of vertebral arches
|
|
GS166718: MP:0002169 no abnormal phenotype detected
|
|
GS201536: GO:0035326 enhancer binding
|
|
GS166160: MP:0011092 complete embryonic lethality
|
|
GS197821: GO:0001702 gastrulation with mouth forming second
|
|
GS196806: GO:0032502 developmental process
|
|
GS208664: GO:0008283 cell proliferation
|
|
GS181215: GO:0007399 nervous system development
|
|
GS203594: GO:0043226 organelle
|
|
GS164182: MP:0000489 abnormal large intestine morphology
|
|
GS205364: GO:0010467 gene expression
|
|
GS207498: GO:0001501 skeletal system development
|
|
GS166203: MP:0005169 abnormal male meiosis
|
|
GS164873: MP:0006281 abnormal tail development
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS170093: MP:0000259 abnormal vascular development
|
|
GS190949: GO:0009058 biosynthetic process
|
|
GS165537: MP:0005376 homeostasis/metabolism phenotype
|
|
GS190906: GO:0048332 mesoderm morphogenesis
|
|
GS164392: MP:0003050 abnormal sacral vertebrae morphology
|
|
GS166246: MP:0002759 abnormal caudal vertebrae morphology
|
|
GS182705: GO:0051173 positive regulation of nitrogen compound metabolic process
|
|
GS136378: obesity QTL 4 (Obq4, Published QTL Chr 17)
|
|
GS166655: MP:0005226 abnormal vertebral arch development
|
|
GS198866: GO:0000785 chromatin
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS201265: GO:0009891 positive regulation of biosynthetic process
|
|
GS207991: GO:0000003 reproduction
|
|
GS177308: GO:1901362 organic cyclic compound biosynthetic process
|
|
GS166405: MP:0002111 abnormal tail morphology
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS135616: circulating hormone level QTL 8 (Chlq8, Published QTL Chr 17)
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS168750: MP:0002191 abnormal artery morphology
|
|
GS184461: GO:0009891 positive regulation of biosynthetic process
|
|
GS196196: GO:0022414 reproductive process
|
|
GS177356: GO:0003674 molecular_function
|
|
GS178885: GO:0003677 DNA binding
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS204831: GO:0061053 somite development
|
|
GS165161: MP:0006206 embryonic lethality between somite formation and embryo turning
|
|
GS180001: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS206220: GO:0060395 SMAD protein signal transduction
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS189356: GO:0060395 SMAD protein signal transduction
|
|
GS204410: GO:0060606 tube closure
|
|
GS136479: periosteal circumference 4 (Pcir4, Published QTL Chr 17)
|
|
GS201321: GO:0090009 primitive streak formation
|
|
GS188410: GO:0032774 RNA biosynthetic process
|
|
GS192471: GO:0048869 cellular developmental process
|
|
GS177754: GO:0001944 vasculature development
|
|
GS180166: GO:0008152 metabolic process
|
|
GS191727: GO:0008283 cell proliferation
|
|
GS192093: GO:0000981 sequence-specific DNA binding RNA polymerase II transcription factor activity
|
|
GS205619: GO:0009880 embryonic pattern specification
|
|
GS167005: MP:0004787 abnormal dorsal aorta morphology
|
|
GS203675: GO:0060379 cardiac muscle cell myoblast differentiation
|
|
GS185588: GO:0007369 gastrulation
|
|
GS136909: vertebral morphology and mechanical traits 14 (Vmmt14, Published QTL Chr 17)
|
|
GS202566: GO:0048705 skeletal system morphogenesis
|
|
GS203072: GO:0090304 nucleic acid metabolic process
|
|
GS198768: GO:0001839 neural plate morphogenesis
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS206669: GO:0000980 RNA polymerase II distal enhancer sequence-specific DNA binding
|
|
GS186891: GO:0001841 neural tube formation
|
|
GS195678: GO:0003700 sequence-specific DNA binding transcription factor activity
|
|
GS201253: GO:0044427 chromosomal part
|
|
GS185659: GO:0090130 tissue migration
|
|
GS190605: GO:0001501 skeletal system development
|
|
GS194241: GO:0035148 tube formation
|
|
GS202572: GO:0048706 embryonic skeletal system development
|
|
GS177426: GO:0009799 specification of symmetry
|
|
GS208604: GO:0001067 regulatory region nucleic acid binding
|
|
GS128599: Ethanol Induced Ataxia Chr#17
|
|
GS164109: MP:0003048 abnormal cervical vertebrae morphology
|
|
GS169233: MP:0000138 absent vertebrae
|
|
GS163811: MP:0004643 abnormal vertebrae number
|
|
GS169179: MP:0000753 paralysis
|
|
GS164509: MP:0001695 abnormal gastrulation
|
|
GS205543: GO:0070013 intracellular organelle lumen
|
|
GS186824: GO:0060379 cardiac muscle cell myoblast differentiation
|
|
GS164390: MP:0005297 spina bifida occulta
|
|
GS168956: MP:0003491 abnormal voluntary movement
|
|
GS168892: MP:0000292 distended pericardium
|
|
GS169365: MP:0000923 abnormal roof plate morphology
|
|
GS164110: MP:0003049 abnormal lumbar vertebrae morphology
|
|
GS187751: GO:0019222 regulation of metabolic process
|
|
GS136804: tibia bone quality traits 6 (Tbqt6, Published QTL Chr 17)
|
|
GS169663: MP:0004703 abnormal vertebral column morphology
|
|
GS193237: GO:0031325 positive regulation of cellular metabolic process
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS184452: GO:0044422 organelle part
|
|
GS204204: GO:0006351 transcription, DNA-dependent
|
|
GS180034: GO:0032502 developmental process
|
|
GS199124: GO:0051716 cellular response to stimulus
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS203748: GO:0001840 neural plate development
|
|
GS170442: MP:0010866 abnormal prenatal body size
|
|
GS181975: GO:0001839 neural plate morphogenesis
|
|
GS194602: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS195683: GO:0003705 RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity
|
|
GS203747: GO:0001841 neural tube formation
|
|
GS169648: MP:0000932 absent notochord
|
|
GS197227: GO:0001570 vasculogenesis
|
|
GS136685: skull morphology 24 (Skull24, Published QTL Chr 17)
|
|
GS185259: GO:0051252 regulation of RNA metabolic process
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS164770: MP:0009250 abnormal appendicular skeleton morphology
|
|
GS202909: GO:0035282 segmentation
|
|
GS168174: MP:0001919 abnormal reproductive system physiology
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS190314: GO:0035295 tube development
|
|
GS168567: MP:0011091 complete prenatal lethality
|
|
GS163531: MP:0004659 abnormal odontoid process morphology
|
|
GS198263: GO:0005488 binding
|
|
GS187249: GO:0072358 cardiovascular system development
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS193009: GO:0042127 regulation of cell proliferation
|
|
GS210016: GO:0060562 epithelial tube morphogenesis
|
|
GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
|
|
GS206355: GO:0023052 signaling
|
|
GS192918: GO:0050896 response to stimulus
|
|
GS84299: ethanol metabolism rate (Published QTL, Chr 17)
|
|
GS204040: GO:0009798 axis specification
|
|
GS206182: GO:0060537 muscle tissue development
|
|
GS190067: GO:0018130 heterocycle biosynthetic process
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS207736: GO:0008595 anterior/posterior axis specification, embryo
|
|
GS169609: MP:0001674 abnormal triploblastic development
|
|
GS202820: GO:0001756 somitogenesis
|
|
GS129074: alloantigen response 1 (Alan1 Published QTL Chr 17)
|
|
GS205266: GO:0032774 RNA biosynthetic process
|
|
GS124312: sodium arsenite interacting genes (MeSH:C017947) in CTD
|
|
GS195977: GO:0007154 cell communication
|
|
GS169234: MP:0000137 abnormal vertebrae morphology
|
|
GS165243: MP:0010770 preweaning lethality
|
|
GS166535: MP:0010865 prenatal growth retardation
|
|
GS207935: GO:0007507 heart development
|
|
GS136549: proteinuria 2 (Ptnu2, Published QTL Chr 17)
|
|
GS179777: GO:0043565 sequence-specific DNA binding
|
|
GS185983: GO:0001756 somitogenesis
|
|
GS178703: GO:0060348 bone development
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS164247: MP:0001680 abnormal mesoderm development
|
|
GS178702: GO:0060349 bone morphogenesis
|
|
GS206953: GO:0018130 heterocycle biosynthetic process
|
|
GS163724: MP:0000436 abnormal head movements
|
|
GS169149: MP:0003400 kinked neural tube
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS164860: MP:0004607 abnormal cervical atlas morphology
|
|
GS165798: MP:0005367 renal/urinary system phenotype
|
|
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS196530: GO:0000976 transcription regulatory region sequence-specific DNA binding
|
|
GS180164: GO:0008150 biological_process
|
|
GS177357: GO:0003676 nucleic acid binding
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS207289: GO:0007338 single fertilization
|
|
GS167505: MP:0008762 embryonic lethality
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS169829: MP:0005385 cardiovascular system phenotype
|
|
GS196772: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS177214: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS182956: GO:0035239 tube morphogenesis
|
|
GS164235: MP:0003087 absent allantois
|
|
GS186562: GO:0009653 anatomical structure morphogenesis
|
|
GS207858: GO:0009059 macromolecule biosynthetic process
|
|
GS186558: GO:0007498 mesoderm development
|
|
GS136260: male hybrid sterility QTL 1 (Mhstq1, Published QTL Chr 17)
|
|
GS136372: obesity QTL 19 (Obq19, Published QTL Chr 17)
|
|
GS202418: GO:0007369 gastrulation
|
|
GS195459: GO:0060349 bone morphogenesis
|
|
GS164262: MP:0002080 prenatal lethality
|
|
GS164511: MP:0001697 abnormal embryo size
|
|
GS167307: MP:0002925 abnormal cardiovascular development
|
|
GS200918: GO:0023019 signal transduction involved in regulation of gene expression
|
|
GS163635: MP:0001933 abnormal litter size
|
|
GS177813: GO:0031974 membrane-enclosed lumen
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS185587: GO:0007368 determination of left/right symmetry
|
|
GS193610: GO:0007389 pattern specification process
|
|
GS192610: GO:0031981 nuclear lumen
|
|
GS166156: MP:0011096 complete embryonic lethality between implantation and somite formation
|
|
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS186757: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS164257: MP:0002085 abnormal embryonic tissue morphology
|
|
GS165362: MP:0004623 thoracic vertebral fusion
|
|
GS166825: MP:0000462 abnormal digestive system morphology
|
|
GS169371: MP:0000929 open neural tube
|
|
GS167918: MP:0000955 abnormal spinal cord morphology
|
|
GS198685: GO:0048522 positive regulation of cellular process
|
|
GS163548: MP:0001689 incomplete somite formation
|
|
GS167813: MP:0000163 abnormal cartilage morphology
|
|
GS201949: GO:0044699 single-organism process
|
|
GS166951: MP:0001156 abnormal spermatogenesis
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS83971: cocaine induced activation 3 (Cocia3, Published QTL, Chr 17)
|
|
GS166697: MP:0001539 decreased caudal vertebrae number
|
|
GS209028: GO:0000981 sequence-specific DNA binding RNA polymerase II transcription factor activity
|
|
GS168549: MP:0000477 abnormal intestine morphology
|
|
GS190950: GO:0009059 macromolecule biosynthetic process
|
|
GS181568: GO:0006357 regulation of transcription from RNA polymerase II promoter
|
|
GS164320: MP:0003861 abnormal nervous system development
|
|
GS166154: MP:0011098 complete embryonic lethality during organogenesis
|
|
GS178461: GO:0009987 cellular process
|
|
GS210555: GO:0007389 pattern specification process
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS198602: GO:0007350 blastoderm segmentation
|
|
GS166291: MP:0011108 partial embryonic lethality during organogenesis
|
|
GS197707: GO:0016331 morphogenesis of embryonic epithelium
|
|
GS167377: MP:0004180 failure of initiation of embryo turning
|
|
GS193268: GO:0005575 cellular_component
|
|
GS169633: MP:0003456 absent tail
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS164196: MP:0009768 impaired somite development
|
|
GS166162: MP:0011090 partial perinatal lethality
|
|
GS203749: GO:0001843 neural tube closure
|
|
GS209215: GO:0007166 cell surface receptor signaling pathway
|
|
GS169379: MP:0004251 failure of heart looping
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS163051: MP:0000267 abnormal heart development
|
|
GS202490: GO:0090130 tissue migration
|
|
GS205784: GO:0007351 tripartite regional subdivision
|
|
GS191721: GO:0008284 positive regulation of cell proliferation
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS163852: MP:0001544 abnormal cardiovascular system physiology
|
|
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS192279: GO:0007166 cell surface receptor signaling pathway
|
|
GS165466: MP:0003632 abnormal nervous system morphology
|
|
GS196863: GO:0030903 notochord development
|
|
GS169835: MP:0005389 reproductive system phenotype
|
|
GS200490: GO:0061061 muscle structure development
|
|
GS203238: GO:0000228 nuclear chromosome
|
|
GS164744: MP:0001730 embryonic growth arrest
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS210610: GO:0048570 notochord morphogenesis
|
|
GS190402: GO:0072175 epithelial tube formation
|
|
GS194493: GO:0001944 vasculature development
|
|
GS191106: GO:0044464 cell part
|
|
GS186227: GO:0090304 nucleic acid metabolic process
|
|
GS168593: MP:0002088 abnormal embryonic growth/weight/body size
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS136226: mandible length 18 (Manln18, Published QTL Chr 17)
|
|
GS163580: MP:0000538 abnormal urinary bladder morphology
|
|
GS181267: GO:0048568 embryonic organ development
|
|
GS194555: GO:0031974 membrane-enclosed lumen
|
|
GS184449: GO:0044427 chromosomal part
|
|
GS177680: GO:0000790 nuclear chromatin
|
|
GS170666: MP:0000270 abnormal heart tube morphology
|
|
GS182813: GO:0061371 determination of heart left/right asymmetry
|
|
GS167833: MP:0001784 abnormal fluid regulation
|
|
GS178927: GO:0003705 RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity
|
|
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS185033: GO:0048598 embryonic morphogenesis
|
|
GS136933: vertebral trabecular bone trait 18 (Vtbt18, Published QTL Chr 17)
|
|
GS164864: MP:0004603 absent vertebral arch
|
|
GS165488: MP:0001701 incomplete embryo turning
|
|
GS169114: MP:0004196 abnormal prenatal growth/weight/body size
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS187708: GO:0009893 positive regulation of metabolic process
|
|
GS204232: GO:0001071 nucleic acid binding transcription factor activity
|
|
GS84300: METH responses for body temperature (Published QTL, Chr 17)
|
|
GS168502: MP:0002058 neonatal lethality
|
|
GS206696: GO:0044702 single organism reproductive process
|
|
GS167805: MP:0000150 abnormal rib morphology
|
|
GS169630: MP:0001785 edema
|
|
GS164126: MP:0001388 abnormal stationary movement
|
|
GS124122: monoisoamyl-2,3-dimercaptosuccinate interacting genes (MeSH:C091888) in CTD
|
|
GS200373: GO:0060070 canonical Wnt receptor signaling pathway
|
|
GS183575: GO:0060070 canonical Wnt receptor signaling pathway
|